Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

250
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
250
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

865
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
865
Long-term Depression01:03

Long-term Depression

2.7K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
2.7K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

251
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
251
Depression: Overview01:18

Depression: Overview

414
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
414
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

325
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
325

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methodological limitations of anxiety screening tools used in migraine studies -a narrative review.

Cephalalgia : an international journal of headache·2026
Same author

Acute SARS-CoV-2 infection and self-reported post-acute cognitive dysfunctions from the Danish EFTER-COVID survey.

Communications medicine·2026
Same author

Feasibility of a Supportive Cancer Care Intervention for Patients With Pre-Existing Severe Mental Disorders-The CASEMED Model.

Psycho-oncology·2026
Same author

Quality in specialist palliative care for patients with pre-existing severe mental disorders: A retrospective cohort study.

Palliative medicine·2026
Same author

Brain reserve in memory regions is associated with the preservation of autobiographical memories after electroconvulsive therapy.

Frontiers in psychiatry·2025
Same author

The Impact of Preexisting Severe Mental Disorders on Cancer Mortality: A Systematic Review and Meta-Analysis.

Acta psychiatrica Scandinavica·2025
Same journal

[Mosaicism as a cause of Cowden syndrome].

Ugeskrift for laeger·2026
Same journal

[Thyrotoxic crisis with cardiogenic shock].

Ugeskrift for laeger·2026
Same journal

[Mindfulness-based cognitive therapy in the treatment of depression].

Ugeskrift for laeger·2026
Same journal

[Fitness].

Ugeskrift for laeger·2026
Same journal

[Risk of developing cataract related to fluoroscopy].

Ugeskrift for laeger·2026
Same journal

[Obturator hernia with small bowel ileus presenting as hip pain in an elderly woman].

Ugeskrift for laeger·2026
See all related articles

Related Experiment Video

Updated: Oct 8, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.9K

[Continuation electroconvulsive therapy for depression].

Simone Normark1, Krzysztof Gbyl, Poul Videbech

  • 1simonenormark@gmail.com.

Ugeskrift for Laeger
|January 4, 2022
PubMed
Summary
This summary is machine-generated.

Continuation electroconvulsive therapy (C-ECT) offers an effective treatment for severe, recurrent, or treatment-resistant depression in patients who have previously responded to ECT. These updated guidelines detail patient selection, administration considerations, and potential adverse effects for C-ECT.

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.3K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.6K

Related Experiment Videos

Last Updated: Oct 8, 2025

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

28.9K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.3K
Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

9.6K

Area of Science:

  • Psychiatry
  • Neurology
  • Pharmacology

Background:

  • Electroconvulsive therapy (ECT) is a recognized and effective treatment for major depressive disorder.
  • Continuation ECT (C-ECT) is a vital therapeutic option for patients with severe, recurrent, or treatment-resistant depression who have shown positive response to an initial ECT course.

Purpose of the Study:

  • To provide an updated set of guidelines for the clinical application of C-ECT in managing depression.
  • To delineate patient profiles most likely to benefit from C-ECT.
  • To outline key considerations prior to C-ECT administration and potential adverse effects.

Main Methods:

  • This review synthesizes current evidence and clinical consensus on C-ECT.
  • Guidelines are developed based on efficacy, patient selection criteria, and safety profiles.
  • Consideration of pre-treatment assessments and management of side effects are included.

Main Results:

  • C-ECT is indicated for specific patient populations with severe or treatment-resistant depression.
  • Clear criteria for patient selection and treatment initiation are established.
  • Guidance on managing potential adverse effects is provided.

Conclusions:

  • Updated guidelines enhance the safe and effective use of C-ECT for selected patients with depression.
  • Adherence to these guidelines can optimize treatment outcomes and patient safety.
  • C-ECT remains a crucial intervention for specific, severe depressive episodes.